Ajanta Pharma Limited (BOM:532331)
2,607.30
-63.10 (-2.36%)
At close: Feb 21, 2025
Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 325.52 billion. The enterprise value is 318.43 billion.
Market Cap | 325.52B |
Enterprise Value | 318.43B |
Important Dates
The last earnings date was Monday, January 27, 2025.
Earnings Date | Jan 27, 2025 |
Ex-Dividend Date | Nov 6, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.87% |
Shares Change (QoQ) | -0.12% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 41.84M |
Valuation Ratios
The trailing PE ratio is 36.26.
PE Ratio | 36.26 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 8.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 35.47 |
EV / Sales | 7.03 |
EV / EBITDA | 25.32 |
EV / EBIT | 28.30 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 69.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 19.47% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 5.61M |
Profits Per Employee | 1.11M |
Employee Count | 8,073 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +23.27% |
50-Day Moving Average | 2,796.02 |
200-Day Moving Average | 2,800.37 |
Relative Strength Index (RSI) | 44.31 |
Average Volume (20 Days) | 6,549 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 45.32 billion and earned 8.98 billion in profits. Earnings per share was 71.57.
Revenue | 45.32B |
Gross Profit | 34.26B |
Operating Income | 11.25B |
Pretax Income | 11.98B |
Net Income | 8.98B |
EBITDA | 12.45B |
EBIT | 11.25B |
Earnings Per Share (EPS) | 71.57 |
Balance Sheet
The company has 7.42 billion in cash and 327.90 million in debt, giving a net cash position of 7.09 billion.
Cash & Cash Equivalents | 7.42B |
Total Debt | 327.90M |
Net Cash | 7.09B |
Net Cash Per Share | n/a |
Equity (Book Value) | 36.77B |
Book Value Per Share | 293.33 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 75.59%, with operating and profit margins of 24.83% and 19.81%.
Gross Margin | 75.59% |
Operating Margin | 24.83% |
Pretax Margin | 26.43% |
Profit Margin | 19.81% |
EBITDA Margin | 27.48% |
EBIT Margin | 24.83% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 2.07%.
Dividend Per Share | 54.00 |
Dividend Yield | 2.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | 0.87% |
Shareholder Yield | 2.94% |
Earnings Yield | 2.76% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
Last Split Date | Jun 22, 2022 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |